Literature DB >> 29364453

Moyamoya syndrome associated with neurofibromatosis type 1 in a pediatric patient.

Natália Battisti Serafini1, Cássio Battisti Serafini2, Alanna Santoro Vinhas3, Marcio Barbosa Godinho4.   

Abstract

Neurofibromatosis type 1 is a multisystem genetic disease of autosomal dominant transmission that reveals important cutaneous manifestations such as café-au-lait spots, multiple neurofibromas, and ephelides in skin fold areas, as well as hamartomatous lesions in the eyes, bones, glands, and central nervous system. Moyamoya disease is a rare progressive vaso-occlusive disorder that occurs with important ischemic cerebrovascular events. Despite the rarity of this association in childhood, children diagnosed with neurofibromatosis type 1 and focal neurologic symptoms should be investigated for moyamoya syndrome. The present study reports the case of a pediatric patient with a rapidly progressive cerebrovascular accident and a late diagnosis of Neurofibromatosis type 1 associated with moyamoya disease.

Entities:  

Mesh:

Year:  2017        PMID: 29364453      PMCID: PMC5786411          DOI: 10.1590/abd1806-4841.20176829

Source DB:  PubMed          Journal:  An Bras Dermatol        ISSN: 0365-0596            Impact factor:   1.896


  10 in total

Review 1.  Neurofibromatosis.

Authors: 
Journal:  Natl Inst Health Consens Dev Conf Consens Statement       Date:  1987 Jul 13-15

Review 2.  Moyamoya disease.

Authors:  M Farrugia; D C Howlett; A M Saks
Journal:  Postgrad Med J       Date:  1997-09       Impact factor: 2.401

3.  [Cerebrovascular chronic occlusive disease (moyamoya): case report].

Authors:  J Adamo; M V Paradela; M Horigushi
Journal:  Arq Neuropsiquiatr       Date:  2001-06       Impact factor: 1.420

4.  [Moyamoya disease: follow-up of 12 patients].

Authors:  I Pascual-Castroviejo; S I Pascual-Pascual; R Velázquez; J Viaño; V Martínez
Journal:  Neurologia       Date:  2006-12       Impact factor: 3.109

Review 5.  Moyamoya disease and moyamoya syndrome.

Authors:  R Michael Scott; Edward R Smith
Journal:  N Engl J Med       Date:  2009-03-19       Impact factor: 91.245

Review 6.  Moyamoya disease in pediatric patients: outcomes of neurosurgical interventions.

Authors:  Anand Veeravagu; Raphael Guzman; Chirag G Patil; Lewis C Hou; Marco Lee; Gary K Steinberg
Journal:  Neurosurg Focus       Date:  2008       Impact factor: 4.047

7.  Neurofibromatosis type 1 association with moyamoya disease.

Authors:  Filiz Koc; Deniz Yerdelen; Zafer Koc
Journal:  Int J Neurosci       Date:  2008-08       Impact factor: 2.292

8.  'Moya' than meets the eye: neurofibromatosis type 1 associated with Moyamoya syndrome.

Authors:  R M Tan; S M Chng; W T Seow; J Wong; C C Lim
Journal:  Singapore Med J       Date:  2008-04       Impact factor: 1.858

9.  Prevalence of plexiform neurofibroma in children and adolescents with type I neurofibromatosis.

Authors:  Luiz G Darrigo; Mauro Geller; Aguinaldo Bonalumi Filho; David R Azulay
Journal:  J Pediatr (Rio J)       Date:  2007-11-30       Impact factor: 2.197

10.  Moyamoya syndrome and neurofibromatosis type 1.

Authors:  Euthymia Vargiami; Evdoxia Sapountzi; Dimitris Samakovitis; Spyros Batzios; Maria Kyriazi; Athanasia Anastasiou; Dimitrios I Zafeiriou
Journal:  Ital J Pediatr       Date:  2014-06-21       Impact factor: 2.638

  10 in total
  1 in total

Review 1.  Western Moyamoya Phenotype: A Scoping Review.

Authors:  Raphael Miller; Santiago R Unda; Ryan Holland; David J Altschul
Journal:  Cureus       Date:  2021-11-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.